체외진단용 시약 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 기술별, 사용별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

In Vitro Diagnostic Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Use, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,588,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,052,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,712,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 체외진단용 시약(IVD) 시장은 2024년에 787억 5,000만 달러로 평가되었으며, 2030년까지 CAGR 5.35%로 성장하여 1,076억 6,000만 달러에 달할 것으로 예측됩니다.

체외진단용(IVD) 시약은 인체 밖에서 시행되는 검사에 필수적인 생화학 또는 생물학적 물질로, 환자 검체 분석을 통해 질병의 검출, 진단, 모니터링, 치료를 가능하게 하는 시약입니다. 전 세계 IVD 시약 시장은 견조한 성장세를 보이고 있으며, 그 주요 요인은 전 세계적으로 증가하는 만성질환 및 감염성 질환의 확산과 고도로 특화된 진단 솔루션을 필요로 하는 맞춤형 의료에 대한 수요 증가에 기인합니다. 정확하고 시기적절한 진단 정보에 대한 이러한 일관된 수요가 시장의 지속적인 확장을 뒷받침하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	787억 5,000만 달러
시장 규모 : 2030년	1,076억 6,000만 달러
CAGR : 2025-2030년	5.35%
가장 빠르게 성장하는 부문	면역측정법
최대 시장	북미

주요 시장 촉진요인

전 세계적으로 만성질환 및 감염성 질환의 확산은 체외 진단 시약의 주요 촉진요인입니다. 암, 당뇨병, 심혈관질환, 신종 감염병 병원체 등의 질병은 선별검사, 정확한 진단 및 질병 관리를 위해 지속적이고 광범위한 진단 검사가 필요합니다.

주요 시장 과제

광범위한 규제 요건은 세계 체외진단(IVD) 시약 시장의 성장을 크게 저해하고 있습니다. 복잡한 인증 프로세스와 장기간의 타임라인은 새로운 진단 제품의 적시 도입과 가용성을 제한하고 있습니다.

주요 시장 동향

분산형 및 현장 검사(POC)로의 전환은 기존의 실험실 환경을 넘어 진단 능력을 확장하고, 검사에 더 가까이 다가갈 수 있으며, 보다 빠른 임상적 판단을 가능하게 합니다. 이러한 추세에 따라 소형 휴대용 장치와 호환되는 견고하고 사용하기 쉬운 시약 제제의 개발이 요구되고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 체외진단용 시약(IVD) 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 유형별(항체, 정제 단백질·펩타이드, 올리고뉴클레오티드, 기타)
  • 기술별(면역측정법, 임상화학, 분자진단, 미생물학, 혈액학, 기타)
  • 용도별(임상 용도, 조사 용도, 기타)
  • 최종사용자별(체외진단 제조업체, 학술기관·연구소, 병원 검사실, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 체외진단용(IVD) 시약 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 체외진단용(IVD) 시약 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 체외진단용(IVD) 시약 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 체외진단용 시약(IVD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 체외진단용(IVD) 시약 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 체외진단용(IVD) 시약 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN N.V.
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd
• Bio-Techne Corp

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global In Vitro Diagnostic (IVD) Reagents Market, valued at USD 78.75 Billion in 2024, is projected to experience a CAGR of 5.35% to reach USD 107.66 Billion by 2030. In vitro diagnostic (IVD) reagents are biochemical or biological substances essential for tests conducted outside the human body, enabling the detection, diagnosis, monitoring, and treatment of diseases by analyzing patient samples. The global IVD reagents market demonstrates robust growth, primarily supported by the increasing worldwide prevalence of chronic and infectious diseases, coupled with a rising demand for personalized medicine which necessitates highly specific diagnostic solutions. This consistent requirement for accurate and timely diagnostic information underpins the sustained expansion of the market.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 78.75 Billion
Market Size 2030	USD 107.66 Billion
CAGR 2025-2030	5.35%
Fastest Growing Segment	Immunoassay
Largest Market	North America

Key Market Drivers

The escalating global prevalence of chronic and infectious diseases is a primary driver for in vitro diagnostic reagents. Conditions such as cancer, diabetes, cardiovascular diseases, and emerging infectious pathogens necessitate continuous and extensive diagnostic testing for screening, accurate diagnosis, and disease management. This persistent need directly increases the consumption of IVD reagents across diverse diagnostic platforms. For example, the substantial global cancer burden underscores this demand.

Key Market Challenges

The extensive regulatory requirements significantly impede the growth of the Global In Vitro Diagnostic (IVD) Reagents Market. The complex certification processes and lengthy timelines restrict the timely introduction and availability of new diagnostic products. For example, according to a MedTech Europe survey in 2024, the choice of the EU as the first launch geography for IVD large manufacturers dropped by 40% due to regulatory burdens, indicating a diversion of innovation away from this critical market. This directly translates to fewer innovative reagents reaching patients and healthcare providers, thus limiting market expansion.

Key Market Trends

The shift towards decentralized and point-of-care (POC) testing is expanding diagnostic capabilities beyond traditional laboratory settings, bringing testing closer to patients and facilitating more immediate clinical decisions. This trend necessitates the development of robust, user-friendly reagent formulations compatible with smaller, often portable devices. Such decentralization is crucial for improving access to timely diagnostics, particularly in remote areas or emergency situations.

Key Market Players

• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN N.V.
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd
• Bio-Techne Corp

Report Scope:

In this report, the Global In Vitro Diagnostic (IVD) Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Vitro Diagnostic (IVD) Reagents Market, By Type:

• Antibodies
• Purified Proteins and Peptides
• Oligonucleotides
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Technology:

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Use:

• Clinical Use
• Research Use
• Others

In Vitro Diagnostic (IVD) Reagents Market, By End User:

• IVD Manufacturers
• Academic Institutes & Research Laboratories
• Hospital Laboratories
• Others

In Vitro Diagnostic (IVD) Reagents Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global In Vitro Diagnostic (IVD) Reagents Market.

Available Customizations:

Global In Vitro Diagnostic (IVD) Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In Vitro Diagnostic (IVD) Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others)
  • 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others)
  • 5.2.3. By Use (Clinical Use, Research Use, Others)
  • 5.2.4. By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Use
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Use
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Use
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Use
      • 6.3.3.2.4. By End User

7. Europe In Vitro Diagnostic (IVD) Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Use
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Use
      • 7.3.1.2.4. By End User
  • 7.3.2. France In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Use
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Use
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Use
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Use
      • 7.3.5.2.4. By End User

8. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Use
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Use
      • 8.3.1.2.4. By End User
  • 8.3.2. India In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Use
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Use
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Use
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Use
      • 8.3.5.2.4. By End User

9. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Use
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Use
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Use
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Use
      • 9.3.3.2.4. By End User

10. South America In Vitro Diagnostic (IVD) Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Use
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Use
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Use
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina In Vitro Diagnostic (IVD) Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Use
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global In Vitro Diagnostic (IVD) Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Bio-Rad Laboratories, Inc
• 15.4. Agilent Technologies, Inc.
• 15.5. QIAGEN N.V.
• 15.6. Merck KGaA
• 15.7. Beckman Coulter, Inc
• 15.8. Hologic, Inc
• 15.9. Abcam Ltd
• 15.10. Bio-Techne Corp

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료